ARDELYX INC
NASDAQ: ARDX (Ardelyx, Inc.)
Kemas kini terakhir: 10 jam lalu5.97
-0.02 (-0.33%)
| Penutupan Terdahulu | 5.99 |
| Buka | 6.05 |
| Jumlah Dagangan | 1,883,996 |
| Purata Dagangan (3B) | 3,552,049 |
| Modal Pasaran | 1,464,127,104 |
| Harga / Pendapatan (P/E Ke hadapan) | 33.11 |
| Harga / Jualan (P/S) | 3.53 |
| Harga / Buku (P/B) | 8.76 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 30 Apr 2026 |
| Margin Keuntungan | -14.86% |
| Margin Operasi (TTM) | -49.04% |
| EPS Cair (TTM) | -0.230 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 61.00% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 124.68% |
| Nisbah Semasa (MRQ) | 4.12 |
| Aliran Tunai Operasi (OCF TTM) | -47.54 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -17.22 M |
| Pulangan Atas Aset (ROA TTM) | -6.58% |
| Pulangan Atas Ekuiti (ROE TTM) | -36.26% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Ardelyx, Inc. | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | -1.5 |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 3.5 |
| Osilator Teknikal | 1.5 |
| Purata | 1.30 |
|
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 2.51% |
| % Dimiliki oleh Institusi | 72.46% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Rock Springs Capital Management Lp | 31 Dec 2025 | 2,299,473 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 19.00 (Wedbush, 218.26%) | Beli |
| Median | 18.00 (201.51%) | |
| Rendah | 17.00 (BTIG, 184.76%) | Beli |
| Purata | 18.00 (201.51%) | |
| Jumlah | 3 Beli | |
| Harga Purata @ Panggilan | 5.74 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Wedbush | 23 Feb 2026 | 19.00 (218.26%) | Beli | 5.75 |
| BTIG | 20 Feb 2026 | 17.00 (184.76%) | Beli | 5.73 |
| 29 Jan 2026 | 17.00 (184.76%) | Beli | 7.85 | |
| HC Wainwright & Co. | 20 Feb 2026 | 18.00 (201.51%) | Beli | 5.73 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| RAAB MICHAEL | - | 6.30 | -41,668 | -262,508 |
| Jumlah Keseluruhan Kuantiti Bersih | -41,668 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -262,508 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 6.30 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| RAAB MICHAEL | Pegawai | 15 Apr 2026 | Jual automatik (-) | 41,668 | 6.30 | 262,508 |
| RAAB MICHAEL | Pegawai | 15 Apr 2026 | Pelaksanaan pilihan | 20,834 | - | - |
| Tarikh | Jenis | Butiran |
|---|---|---|
| 05 Feb 2026 | Pengumuman | Ardelyx to Report Full Year and Fourth Quarter 2025 Financial Results on February 19, 2026 |
| 03 Feb 2026 | Pengumuman | Ardelyx Receives New Patent for Tenapanor |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |